Related Experiment Videos
[To unity traditional and western sciences and modern pharmacology]
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]
|January 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Associations between 4 lipid biomarkers and cardiometabolic multimorbidity development in middle aged and old adults in China].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2024
[Survival analysis since diagnosis of HIV-positive injecting drug users aged 15 years and above in China].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2022
[Epidemiological characteristics of newly reported HIV-infected adolescents aged 15-17 years outside school in China, 2011-2019].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2022
[Retrospective analysis of diagnosis and treatment of breast cancer in pregnancy].
Zhonghua wai ke za zhi [Chinese journal of surgery]·2018
[Prevalence and influencing factors on psychological violence from parents to child].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2016
[Nitric Oxide Signaling Pathway and Vascular Activity].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[The Regulation Effects of Carbon Monoxide in Cardiovascular Systems].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Research Progress in the Neurobiological Effects of Hydrogen Sulfide].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Adipocytic Endogenous Hydrogen Sulfide-Function,Regulation and Diseases].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Role Ofhydrogen Sulfide on Inflammatory Immune Disorders in Cardiovascular Diseases].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Research Advances in Hydrogen Sulfide and Diabetes Mellitus as Well as Diabetic Complications].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Pharmacologic treatment of dystonia].
Medicina·2026
Oral vs. Subcutaneous Semaglutide for Obesity Treatment: A Systematic Review of Efficacy, Safety, and Patient-Oriented Outcomes.
Pharmaceuticals (Basel, Switzerland)·2026
Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors.
Pharmaceuticals (Basel, Switzerland)·2026
Novel Roles of Urokinase- and Tissue-Type Plasminogen Activators in Substance Use Disorders: A Narrative Review of Molecular Mechanisms and Translational Perspectives.
International journal of molecular sciences·2026